Prepare AI usage evidence for a board decision
A board needs to understand the organization's exposure, the controls in place and the decisions leadership must make. A chart of AI activity is only one input. Explain what the reporting can see, what it cannot see and which conclusions are supported by the evidence.
For CISOs, risk leaders and executive reporting owners
Directors ask whether employee AI use is under control
The reporting owner has usage charts, policy events and a list of approved tools. They must turn these into a short briefing without presenting every event as a security incident.
What you are working with
- The reporting period and the deployed population in scope.
- Observed usage, tested control outcomes and unresolved exceptions.
- Specific decisions about rollout, ownership or risk acceptance.
A safer approach
- State the visibility denominator beside each activity trend.
- Keep policy events separate from confirmed incident findings.
- Connect each requested decision to evidence and an accountable owner.
Expected outcome: The briefing makes the control position understandable and identifies the remaining work without implying that all enterprise AI activity has been measured.
Work through the procedure
Start with the decision the board faces
Define whether the briefing seeks a rollout decision, a change in risk appetite or assurance about an existing program. Select evidence that helps resolve that question. Put exploratory observations in supporting material rather than making a large inventory the main story.
Define the scope of every metric
Record the period, population, collection source and known exclusions. Separate active users from licensed users, discovered tools from controlled workflows, and policy events from confirmed exposure. Explain changes in deployment coverage before interpreting a rising or falling activity line.
Pair policy claims with operating evidence
For a material control, show the stated rule, the tested submission path, the observed outcome and the limitation. Summarize exceptions and unresolved findings with owners. Use aggregated or minimized examples so board reporting does not unnecessarily reproduce employee prompts or client documents.
Ask for a clear action and follow-up
Finish with the decision requested, responsible executive and evidence expected at the next review. Have the data and control owners verify the briefing. Keep a versioned record of what was presented so later reports can explain scope or methodology changes.
What to check before proceeding
1. Trends have comparable coverage
- Ready when
- Changes in population or collection are disclosed alongside the comparison.
- If the check fails
- Label the periods as non-comparable instead of claiming a change in risk.
2. Control statements have tested scope
- Ready when
- The briefing identifies the app, surface and action that were verified.
- If the check fails
- Present the statement as a validation task rather than operating assurance.
3. The requested decision is actionable
- Ready when
- Directors can identify the choice, accountable owner and unresolved uncertainty.
- If the check fails
- Replace general calls for stronger governance with a specific proposal.
Common mistakes to avoid
- Treating more policy detections after a rollout as proof that employees suddenly became less careful.
- Converting usage volume into time saved, productivity or financial return without a separate validated measurement method.
Evaluate this workflow with Aona
Where Aona can help
Aona's usage and policy information can contribute to reporting about supported, observed workflows. Pair it with deployment records and control tests so leadership understands the coverage behind the figures.
What to confirm
Activity analytics do not establish company-wide coverage, legal compliance, avoided breaches or productivity gains. A board-ready conclusion still requires human interpretation and evidence beyond a product dashboard.
Need a defensible view of employee AI use?
Review your visibility requirements and a sample AI inventory. Discuss which endpoints must be covered and what the evidence can—and cannot—tell your leadership team.